Five current and former AstraZeneca employees reportedly have been detained by police in China in connection with alleged ...

Police in China have detained five current and former employees of British drugmaker AstraZeneca Plc for questioning about ...

AstraZeneca said Chinese authorities detained some of its employees in Shenzhen for alleged violations of data-privacy laws and importing an unapproved cancer drug. A spokesman for the drugmaker said ...

Biogen's efforts to replenish its multiple sclerosis pipeline have suffered a setback, after the FDA placed a clinical hold on a drug ... in China as a second-line therapy for two blood cancer ...

The FDA has lifted the partial clinical hold on MediLink Therapeutics’ Phase 1 trial for BNT326/YL202, a HER3-targeting antibody-drug conjugate ... non-small cell lung cancer or HR+/HER2 ...

For decades drugmakers have taken a more-is-more model when dosing cancer drugs in clinical trials. U.S. regulators want them to reconsider that approach. Companies with cancer drugs in clinical ...

The FDA approved vorasidenib earlier this month ... causes tumor cells to grow," Dr. Katy Peters explained. "What the drug does is it actually inhibits that mutant protein." Peters, also with ...

The U.S. Food and Drug Administration (FDA) has approved a new drug for certain adult patients with endometrial cancer. Jemperli (dostarlimab-gxly) — made by British pharmaceutical company GSK ...

GDANSK, Aug 19 (Reuters) - BioNTech (22UAy.DE), opens new tab on Monday said the U.S. Food and Drug Administration (FDA ... China-based MediLink, in patients with types of non-small cell lung ...

Police in China have detained five current and former employees of British drugmaker AstraZeneca Plc for questioning about ...